Three-in-one TB drug approved.
D017277:Drug Approval; D004359:Drug Therapy, Combination; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000627:therapeutic use*; D011718:Pyrazinamide / Q000008:administration & dosage / Q000627:therapeutic use*; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use*; D014376:Tuberculosis / Q000188:drug therapy*; D014486:United States Food and Drug Administration
D011718:Pyrazinamide; D007538:Isoniazid; D012293:Rifampin